Navigation Links
In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team

Kris Freeman hopes for first U.S. cross-country medal since 1976; health issues plagued 2006 Olympic bid

INDIANAPOLIS, Jan. 19 /PRNewswire-USNewswire/ -- Kris Freeman is back in the hunt for an Olympic medal in Vancouver after being named today to the U.S. ski team following a disappointing finish at the 2006 Games in Torino, Italy.  Freeman, who is expected to compete in up to five events at the 2010 Games in February, suffers from type 1 diabetes, a form of the disease where the body does not produce insulin needed to regulate blood sugar.  Freeman is sponsored by Eli Lilly Company (Lilly), which makes the insulin that he depends on as a life-saving treatment.

Freeman is expected to compete for a medal in as many as five Olympic events spanning the breadth of the Vancouver Games, including the 15 km freestyle, the individual sprint, the 30 km pursuit, the team sprint, and the 50 km mass start classic.  Bill Koch won a silver medal in cross-country skiing in the 1976 Innsbruck Games in Austria, the only American to have medaled in the sport.

A key marker on Freeman's comeback trail is how he is now treated for type 1 diabetes.  To compete in the 2010 Games, Freeman will wear a small device, called an insulin pump, which provides an adjustable supply of insulin to help manage his diabetes even while racing.  

Diagnosed with type 1 diabetes in 2000 at age 19, Freeman was told he would never be able to compete as an Olympian because of his diabetes.

"I'm motivated to win for my country and myself, but to also prove to detractors that it's possible to compete against the world's best cross-country skiers, even with type 1 diabetes," said Freeman.

Freeman's return to elite competition is even more anticipated after he contracted the flu during the 2006 Games and underwent surgery in both legs last spring to alleviate debilitating pain caused by a rare muscle disorder called compartment syndrome.

Off the snow, Freeman focuses on diabetes education. He travels for sponsor Eli Lilly and Company to children's diabetes camps across the U.S. to speak to campers about their disease. To date, he has met with more than 3,000 youngsters nationwide.

"I have a blast meeting the campers, but more importantly, I want them to see that a person with diabetes can do almost anything he or she puts his mind to, including competing in the Olympics," said Freeman.

In competition, Freeman is a 13-time U.S. National cross-country champion and recently had his best finish at the 2009 World Championships and the best U.S. finish in any cross-country event in more than two decades. He came in fourth in November's World Cup 15 km classic in Kuusamo, Finland.

At the 2002 Olympics in Salt Lake City, Freeman placed 22nd in the 15 km classic and 14th in the 30 km pursuit. He also logged the sixth fastest time overall in the 4 x 10 km team relay, helping the U.S. team secure fifth place — the best Olympic finish for the U.S. cross-country team in history. In 2003, Freeman finished sixth and fifth in two consecutive World Cups, and finished 22nd in the 15 km classic at the 2006 Winter Games in Torino, Italy.

For more information about Freeman's work with Lilly, please visit For the full 2010 U.S. Olympic cross-country event schedule visit

About Lilly Diabetes

For more than 85 years, Eli Lilly and Company (Lilly) has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy -- practical tools, education and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journey of each person living with or treating diabetes inspires ours. For more information, visit

About Eli Lilly and Company

Eli Lilly and Company, a leading innovation-driven company, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Information about Lilly is available at

SOURCE Eli Lilly and Company



SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Cross-Country Walker to Finish His Journey for Cancer Research
2. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
3. Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
4. Weekend Admission May Be Riskier for GI Bleeding
5. Adverse housing conditions contribute to diabetes risk
6. RAND finds cases of undiagnosed diabetes drop sharply
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Diabetes appears to increase risk of death for patients with acute coronary syndromes
9. Discovery of sugar sensor in intestine could benefit diabetes
10. Despite overeating, morbidly obese mice gain protection against diabetes
11. Heart Attack Boosts Diabetes Risk
Post Your Comments:
(Date:11/30/2015)... Atlanta (PRWEB) , ... November 30, 2015 , ... Using ... detection of prediabetes in American children and adults, according to a new study by ... Improving Detection of Prediabetes in Children and Adults: Using Combinations of Blood Glucose Tests ...
(Date:11/30/2015)... ... ... Newly reviewed and approved “NJ Top Dentist”, Paul Dionne, ... both advanced training and considerable experience in reconstructive dentistry with attention to occlusal ... He is an active Spear Education member providing full mouth restorative and ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations ... and KingMed Diagnostics researchers. Their review of more than 1,500 ... UPMC pathologists resulted in significantly altered treatment plans for more than half of ...
(Date:11/30/2015)... New York, NY (PRWEB) , ... November 30, 2015 , ... ... New York Times,” will be released on December 1, 2015, to coincide with World ... book about the groundbreaking journalist who covered the AIDS epidemic as he was dying ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic pain, ... at the U.S. Patent and Trademark Office (USPTO) has denied ... Patent No. 8,359,102 (the ,102 patent).  ... unit of Boston Scientific Corporation filed two petitions challenging the ...
(Date:11/30/2015)... , Nov. 30, 2015 ... the "Orphan Drugs Market 2015-2019" report ... has announced the addition of the "Orphan ... --> Research and Markets ( ... "Orphan Drugs Market 2015-2019" report to their ...
(Date:11/30/2015)... global cell culture market is expected ... bn by 2022 at a CAGR of 7.1% therein. --> ... its 2013 value of US$6.1 bn to US$11.3 bn by 2022 ... Research has announced the release of a new market research study, ... ,Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends ...
Breaking Medicine Technology: